<DOC>
	<DOCNO>NCT01276327</DOCNO>
	<brief_summary>The objective current study establish bioequivalence linagliptin/ pioglitazone fix dose combination tablet compare single tablet linagliptin pioglitazone administer together .</brief_summary>
	<brief_title>Bioequivalence Fixed Dose Combination Tablet Linagliptin/Pioglitazone Compared With Its Mono-components</brief_title>
	<detailed_description />
	<mesh_term>Pioglitazone</mesh_term>
	<mesh_term>Linagliptin</mesh_term>
	<criteria>Inclusion criterion : Healthy male female subject Exclusion criterion : Any relevant deviation healthy condition</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2014</verification_date>
</DOC>